2012 Symposium Guest Speakers Teresa Kimberley , M.D. Associate professor at the University of Minnesota in the Department of Physical Medicine and Rehabilitation Dr. Teresa Kimberley is an associate professor at the University of Minnesota in the Department of Physical Medicine and Rehabilitation, Program in Physical Therapy. She co-directs the Brain Plasticity Lab, which helped […]
2012 Symposium Guest Speakers Mark Ledoux, M.D., PhD Professor of Neurology, University of Tennessee Health Science Center Dr. LeDoux is a professor of neurology at the University of Tennessee Health Science Center, as well as the director of both the Dystonia Clinic and the Movement Disorders Research Laboratories. He is the recipient of several awards, […]
2012 Symposium Guest Speakers Jill Ostrem, M.D. Assistant Professor of Neurology in the UCSF School of Medicine Dr. Jill Ostrem specializes in the medical and surgical treatments of movement disorders, such as Parkinson’s disease, essential tremor and dystonia. She is particularly interested in treatments such as deep brain stimulation and gene therapy as well as […]
2012 Symposium Guest Speakers Brenda Wieber, RN, BSN, CPC Regional Reimbursement Manager for Merz Pharmaceuticals Brenda Wieber, RN, BSN, CPC, is a Regional Reimbursement Manager for Merz Pharmaceuticals. She earned her BS degree in Nursing at the University of Minnesota. With over 16 years of experience in the healthcare industry, Ms Wieber was a critical […]
2012 Symposium Guest Speakers Jay A. Van Gerpen, M.D. Assistant Professor of Neurology at the Mayo Clinic Florida Dr. Van Gerpen is an Assistant Professor of Neurology at the Mayo Clinic Florida in Jacksonville. Dr. Van Gerpen graduated from the Vanderbilt University School of Medicine in Nashville Tennessee. He completed neurology residency at the University […]
I am pleased to announce that we are hosting the 2012 symposium in New Orleans, Louisiana. The symposium will take place on the weekend of October 20 and 21. We have a great line up of guest speakers for this symposium with interesting topics. The following is the Symposium schedule with guest speakers and topics. […]
Dissertation on “Cervical Dystonia and the Black Community.” February 15, 2012 My Life with Cervical Dystonia! My name is Karen Chandler and I have cervical dystonia. I was born in Panama (Afro-Hispanic and I do not speak lick of Spanish, lol) and raised sin California, Michigan, and Florida. I was diagnosed with CD while I […]
Merz Pharmaceuticals Receives J-Code For Xeomin (incobotulinumtoxinA) January 10, 2012 Permanent Product-Specific Code Will Help Simplify Billing And Reimbursement GREENSBORO, N.C., January 4, 2012 /PRNewswire/ — Merz Pharmaceuticals, LLC, today announced that the Centers for Medicare and Medicaid Services (CMS) has assigned a product-specific Healthcare Common Procedure Coding System (HCPCS) billing code, J0588 “INJECTION, INCOBOTULINUMTOXIN […]
2011 NSTA Symposium Information Las Vegas, Nevada – October 22nd and 23rd December 5, 2011 The 2011 NSTA symposium in Las Vegas, Nevada has passed and I am happy to report it was a huge success! We had over 130 people in attendance and the room was packed! We had so many people registering at […]
Programs Feature Simple Enrollment and Meaningful Financial Assistance March 8, 2011 Allergan, Inc. is seeking patients who are or will be receiving onabotulinumtoxinA injections for the treatment of cervical dystonia for potential observational study participation. Eligible patients may receive a patient stipend for their participation. The CD-PROBE Study is a Multi-center, Prospective, Naturalistic, Observational Registry of Cervical […]
Merz Pharmaceuticals Joins Patient Advocates To Raise Awareness Of Cervical Dystonia and Blepharospasm
March 9, 2011 Ipsen, manufacturer of Dysport for Injection (also known in the US as abobotulinumtoxinA neurotoxin), is contacting physicians to conduct an observational registry stud. The goal of the registry, ANCHOR-CD, is to collect and evaluate typical treatment response information from cervical dystonia patients currently being treated with market-available Dysport. The registry will recruit up to 400 […]